ea0046oc1 | (1) | UKINETS2016
Boyce Malcolm
, Moore Andrew
, Parsons Bryony
, Lloyd Katie
, Sagatun Liv
, Thomsen Liv
, Varro Andrea
, Fossmark Reidar
, Waldum Helge
, Pritchard David M
Introduction: In a two-centre, 12-week, open trial in 16 patients with autoimmune chronic atrophic gastritis, hypergastrinaemia, multiple type 1 gastric neuroendocrine tumours (NETs), and raised circulating CgA, the gastrin/CCK2 receptor antagonist (CCK2RA), netazepide, reduced the tumour number and size, and normalised CgA.Aim(s): To treat those patients with netazepide for longer, and to identify new biomarkers.Materials and meth...